Cyamemazine

CAS : 3546-03-0

Ref. 3D-FC156977

Informations sur le produit

• Nom: Cyamemazine
• Marque: Biosynth
• Description: Cyamemazine is a neuroleptic medication, which is a member of the phenothiazine class of compounds. It is synthesized from derivatives of phenothiazine, a group of agents primarily found in pharmaceuticals. The mode of action of cyamemazine involves antagonism at dopamine D2 receptors in the central nervous system. This inhibition of dopamine activity is the principal mechanism through which it exerts its antipsychotic effects. Due to its receptor activity, cyamemazine is used primarily in the management of various psychotic disorders, including schizophrenia and acute psychoses. It also exhibits anxiolytic properties, making it effective in treating anxiety associated with these conditions. By modulating neurotransmitter pathways, cyamemazine helps to alleviate symptoms such as hallucinations, delusions, and agitation, offering therapeutic benefit in complex neuropsychiatric cases. As an atypical antipsychotic, it provides an option for patients who may not respond adequately to other treatments. Although primarily used in a clinical setting, ongoing research continues to investigate potential wider applications and efficacy in treating other mental health issues.

Propriétés chimiques

• Masse moléculaire: 323.46 g/mol
• Formule: C₁₉H₂₁N₃S
• Degré de pureté: Min. 98 Area-%
• Couleur/Forme: Powder
• SMILES: CC(CN(C)C)CN1c2ccccc2Sc2ccc(C#N)cc21